Heme oxygenase-derived carbon monoxide restores vascular function in type 1 diabetes

Drug Metabolism Letters

Volumn 2, Issue 4, 2008, Pages 290-300

  Rodella, Luigi F ^b   Vanella, Luca ^a   Peterson, Stephen J ^a   Drummond, George ^a   Rezzani, Rita ^b   Falck, John R ^c   Abraham, Nader G ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

^b UNIVERSITY OF BRESCIA   (Italy)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Adiponectin; Carbon monoxide; Diabetes; Inflammation; Thrombomodulin; Vascular repair

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; ADIPONECTIN; CARBON MONOXIDE; CASPASE 3; CD31 ANTIGEN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; HEME OXYGENASE 1; INTERCELLULAR ADHESION MOLECULE 1; MESOPORPHYRIN TIN; PROTEIN BCL 2; PROTEIN KINASE B; PROTOPORPHYRIN COBALT; RESVERATROL; THROMBOMODULIN; TRICARBONYLCHLOROGLYCINATO RUTHENIUM; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1; ORGANOMETALLIC COMPOUND; PROTOPORPHYRIN; STILBENE DERIVATIVE; STREPTOZOCIN; TRICARBONYLCHLORO(GLYCINATO)RUTHENIUM(II);

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROTECTION; CONTROLLED STUDY; DRUG MECHANISM; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; INFLAMMATION; INSULIN DEPENDENT DIABETES MELLITUS; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; VASCULAR DISEASE; VASCULAR ENDOTHELIUM; ANIMAL; AORTA; BLOOD; DRUG EFFECT; ENZYME INDUCTION; EXPERIMENTAL DIABETES MELLITUS; GENE EXPRESSION REGULATION; METABOLISM; PATHOPHYSIOLOGY; SPRAGUE DAWLEY RAT;

RATTUS;

ADIPONECTIN; ANIMALS; AORTA; CARBON MONOXIDE; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 1; ENDOTHELIAL CELLS; ENZYME INDUCTION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HEME OXYGENASE-1; MALE; ORGANOMETALLIC COMPOUNDS; PROTOPORPHYRINS; RATS; RATS, SPRAGUE-DAWLEY; STILBENES; STREPTOZOCIN;

EID: 65249172474     PISSN: 18723128     EISSN: None     Source Type: Journal    
DOI: 10.2174/187231208786734058     Document Type: Article

References (61)

1. Touyz, R.M. Endothelial cell IL-8, a new target for adiponectin: implications in vascular protection. Circ. Res., 2005, 97, 1216.
2. Altinova, A.E.; Toruner F.; Bozkurt N.; Bukan N.; Karakoc A.; Yetkin I.; Ayvaz G.; Cakir N. and Arslan M. Circulating concentrations of adiponectin and tumor necrosis factor-alpha in gestational diabetes mellitus. Gynecol. Endocrinol., 2007, 23, 161.
3. Hopkins, T.A.; Ouchi N.; Shibata R. and Walsh K. Adiponectin actions in the cardiovascular system. Cardiovasc. Res., 2007, 74, 11.
4. Minoura, H.; Takeshita S.; Kimura C.; Hirosumi J.; Takakura S.; Kawamura I.; Seki J.; Manda T. and Mutoh S. Mechanism by which a novel non-thiazolidinedione peroxisome proliferatoractivated receptor gamma agonist, FK614, ameliorates insulin resistance in Zucker fatty rats. Diabetes Obes. Metab., 2007, 9, 369.
5. Bahia, L.; Aguiar L.G.; Villela N.; Bottino D.; Godoy-Matos A.F.; Geloneze B.; Tambascia M. and Bouskela E. Adiponectin is associated with improvement of endothelial function after rosiglitazone treatment in non-diabetic individuals with metabolic syndrome. Atherosclerosis, 2007, 195, 138.
6. Bakkaloglu, S.A.; Soylemezoglu O.; Buyan N.; Oktar S.O.; Funahashi T.; Pasaoglu H.; Elhan A.H.; Peru H. and Hasanoglu E. Adiponectin levels and arteriosclerotic risk factors in pediatric renal transplant recipients. Pediatr. Transplant., 2006, 10, 187.
7. Haider, D.G.; Schindler K.; Bohdjalian A.; Prager G.; Luger A.; Wolzt M. and Ludvik B. Plasma adipocyte and epidermal fatty acid binding protein is reduced after weight loss in obesity. Diabetes Obes. Metab., 2007, 9, 761.
8. Ohashi, K.; Kihara S.; Ouchi N.; Kumada M.; Fujita K.; Hiuge A.; Hibuse T.; Ryo M.; Nishizawa H.; Maeda N.; Maeda K.; Shibata R.; Walsh K.; Funahashi T. and Shimomura I. Adiponectin replenishment ameliorates obesity-related hypertension. Hypertension, 2006, 47, 1108.
9. Abraham, N.G.; Kushida T.; McClung J.; Weiss M.; Quan S.; Lafaro R.; Darzynkiewicz Z. and Wolin M. Heme oxygenase-1 attenuates glucose-mediated cell growth arrest and apoptosis in human microvessel endothelial cells. Circ. Res., 2003, 93, 507.
10. Lorenzi, M.; Nordberg J.A. and Toledo S. High glucose prolongs cell-cycle traversal of cultured human endothelial cells. Diabetes, 1987, 36, 1261.
11. Baumgartner-Parzer, S.M.; Wagner L.; Pettermann M.; Grillari J.; Gessl A. and Waldhausl W. High-glucose--triggered apoptosis in cultured endothelial cells. Diabetes, 1995, 44, 1323.
12. Lin, Y.; Berg A.H.; Iyengar P.; Lam T.K.; Giacca A.; Combs T.P.; Rajala M.W.; Du X.; Rollman B.; Li W.; Hawkins M.; Barzilai N.; Rhodes C.J.; Fantus I.G.; Brownlee M. and Scherer P.E. The hyperglycemia-induced inflammatory response in adipocytes: the role of reactive oxygen species. J. Biol. Chem., 2005, 280, 4617.
13. Furukawa, S.; Fujita T.; Shimabukuro M.; Iwaki M.; Yamada Y.; Nakajima Y.; Nakayama O.; Makishima M.; Matsuda M. and Shimomura I. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin. Invest., 2004, 114, 1752.
14. L'Abbate, A.; Neglia D.; Vecoli C.; Novelli M.; Ottaviano V.; Baldi S.; Barsacchi R.; Paolicchi A.; Masiello P.; Drummond G.; McClung J. and Abraham N. Beneficial effect of heme oxygenase-1 expression in myocardial ischemia-reperfusion increases adiponectin in mildly diabetic rats. Am. J. Phyisiol. Heart Circ. Physiol., 2007, 293, H3532-H3541.
15. Da Ros, R.; Assaloni R. and Ceriello A. Antioxidant therapy in diabetic complications: what is new? Curr. Vasc. Pharmacol., 2004, 2, 335.
16. Zou, M.H.; Shi C. and Cohen R.A. High glucose via peroxynitrite causes tyrosine nitration and inactivation of prostacyclin synthase that is associated with thromboxane/prostaglandin H2 receptormediated apoptosis and adhesion molecular expression in cultured human aortic endothelial cells. Diabetes, 2002, 51, 198.
17. Ceriello, A.; dello R.P.; Amstad P. and Cerutti P. High glucose induces antioxidant enzymes in human endothelial cells in culture. Evidence linking hyperglycemia and oxidative stress. Diabetes, 1996, 45, 471.
18. Baynes, J.W. Role of oxidative stress in development of complications in diabetes. Diabetes, 1991, 40, 405.
19. Scheffer, P.G.; Henry R.M.; Wever E.J.; van Rooij G.J.; Bos G.; Heine R.J.; Dekker J.M.; Diamant M.; Stehouwer C.D.; Nijpels G.; Blankenstein M.A. and Teerlink T. LDL oxidative modifications in well- or moderately controlled type 2 diabetes. Diabetes Metab. Res. Rev., 2004, 20, 298.
20. Vasa, M.; Fichtlscherer S.; Aicher A.; Adler K.; Urbich C.; Martin H.; Zeiher A.M. and Dimmeler S. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ. Res., 2001, 89, E1-E7.
21. Challah, M.; Nadaud S.; Philippe M.; Battle T.; Soubrier F.; Corman B. and Michel J.B. Circulating and cellular markers of endothelial dysfunction with aging in rats. Am. J. Physiol., 1997, 273, H1941-H1948.
22. Woywodt, A.; Streiber F.; de Groot K.; Regelsberger H.; Haller H. and Haubitz M. Circulating endothelial cells as markers for ANCAassociated small-vessel vasculitis. Lancet, 2003, 361, 206.
23. Quan, S.; Kaminski P.M.; Yang L.; Morita T.; Inaba M.; Ikehara S.; Goodman A.I.; Wolin M.S. and Abraham N.G. Heme oxygenase-1 prevents superoxide anion-associated endothelial cell sloughing in diabetic rats. Biochem. Biophys. Res. Commun., 2004, 315, 509.
24. Panahian, N.; Maines M.D. Assessment of induction of biliverdin reductase in a mouse model of middle cerebral artery occlusion. Brain Res. Brain Res. Protoc., 2000, 6, 53.
25. Kruger, A.L.; Peterson S.; Turkseven S.; Kaminski P.M.; Zhang F.F.; Quan S.; Wolin M.S. and Abraham N.G. D-4F induces heme oxygenase-1 and extracellular superoxide dismutase, decreases endothelial cell sloughing, and improves vascular reactivity in rat model of diabetes. Circulation, 2005, 111, 3126.
26. Turkseven, S.; Kruger A.; Mingone C.J.; Kaminski P.; Inaba M.; Rodella L.F.; Ikehara S.; Wolin M.S. and Abraham N.G. Antioxidant mechanism of heme oxygenase-1 involves an increase in superoxide dismutase and catalase in experimental diabetes. Am. J. Physiol. Heart Circ. Physio., 2005, 289, H701-H707.
27. Di Noia, M.A.; Van D.S.; Palmieri F.; Yang L.M.; Quan S.; Goodman A.I. and Abraham N.G. Heme oxygenase-1 enhances renal mitochondrial transport carriers and cytochrome C oxidase activity in experimental diabetes. J. Biol. Chem., 2006, 281, 15687.
28. Rodella, L.; Lamon B.D.; Rezzani R.; Sangras B.; Goodman A.I.; Falck J.R. and Abraham N.G. Carbon monoxide and biliverdin prevent endothelial cell sloughing in rats with type I diabetes. Free Radic. Biol. Med., 2006, 40, 2198.
29. Liu, X.; Wei J.; Peng D.H.; Layne M.D. and Yet S.F. Absence of heme oxygenase-1 exacerbates myocardial ischemia/reperfusion injury in diabetic mice. Diabetes, 2005, 54, 778.
30. Pileggi, A.; Molano R.D.; Berney T.; Cattan P.; Vizzardelli C.; Oliver R.; Fraker C.; Ricordi C.; Pastori R.L.; Bach F.H. and Inverardi L. Heme oxygenase-1 induction in islet cells results in protection from apoptosis and improved in vivo function after transplantation. Diabetes, 2001, 50, 1983.
31. Ye, J.; Laychock S.G. A protective role for heme oxygenase expression in pancreatic islets exposed to interleukin-1beta. Endocrinology, 1998, 139, 4155.
32. Laszik, Z.G.; Zhou X.J.; Ferrell G.L.; Silva F.G. and Esmon C.T. Down-regulation of endothelial expression of endothelial cell protein C receptor and thrombomodulin in coronary atherosclerosis. Am. J. Pathol., 2001, 159, 797.
33. Sandusky, G.; Berg D.T.; Richardson M.A.; Myers L. and Grinnell B.W. Modulation of thrombomodulin-dependent activation of human protein C through differential expression of endothelial Smads. J. Biol. Chem., 2002, 277, 49815.
34. Morange, P.E.; Simon C.; Alessi M.C.; Luc G.; Arveiler D.; Ferrieres J.; Amouyel P.; Evans A.; Ducimetiere P. and Juhan-Vague I. Endothelial cell markers and the risk of coronary heart disease: the Prospective Epidemiological Study of Myocardial Infarction (PRIME) study. Circulation, 2004, 109, 1343.
35. Waugh, J.M.; Li-Hawkins J.; Yuksel E.; Kuo M.D.; Cifra P.N.; Hilfiker P.R.; Geske R.; Chawla M.; Thomas J.; Shenaq S.M.; Dake M.D. and Woo S.L. Thrombomodulin overexpression to limit neointima formation. Circulation, 2000, 102, 332.
36. Meleth, A.D.; Agron E.; Chan C.C.; Reed G.F.; Arora K.; Byrnes G.; Csaky K.G.; Ferris F.L., III and Chew E.Y. Serum inflammatory markers in diabetic retinopathy. Invest. Ophthalmol. Vis. Sci., 2005, 46, 4295.
37. Wagener, F.A.; da Silva J.L.; Farley T.; de W.T.; Kappas A. and Abraham N.G. Differential effects of heme oxygenase isoforms on heme mediation of endothelial intracellular adhesion molecule 1 expression. J. Pharmacol. Exp. Ther., 1999, 291, 416.
38. Kushida, T.; LiVolti G.; Goodman A.I. and Abraham N.G. TNFalpha-mediated cell death is attenuated by retrovirus delivery of human heme oxygenase-1 gene into human microvessel endothelial cells. Transplant. Proc., 2002, 34, 2973.
39. Murohara, T.; Delyani J.A.; Albelda S.M. and Lefer A.M. Blockade of platelet endothelial cell adhesion molecule-1 protects against myocardial ischemia and reperfusion injury in cats. J. Immunol., 1996, 156, 3550.
40. Ruotsalainen, E.; Vauhkonen I.; Salmenniemi U.; Pihlajamaki J.; Punnonen K.; Kainulainen S.; Jalkanen S.; Salmi M. and Laakso M. Markers of endothelial dysfunction and low-grade inflammation are associated in the offspring of type 2 diabetic subjects. Atherosclerosis, 2007, 197, 271.
41. Abraham NG; Kappas A. Pharmacological and clinical aspects of heme oxygenase. Pharmacol. Rev., 2008, 60, 79.
42. Kaide, J.-I.; Zhang F.; Wei Y.; Jiang H.; Yu C.; Wang W.H.; Balazy M.; Abraham N.G. and Nasjletti A. Carbon monoxide of vascular origin attenuates the sensitivity of renal arterial vessels to vasoconstrictors. J. Clin. Invest., 2001, 107, 1163.
43. Guo, Z.; Xia Z.; Yuen V.G. and McNeill J.H. Cardiac expression of adiponectin and its receptors in streptozotocin-induced diabetic rats. Metabolism, 2007, 56, 1363.
44. Fukushima, M.; Hattori Y.; Tsukada H.; Koga K.; Kajiwara E.; Kawano K.; Kobayashi T.; Kamata K. and Maitani Y. Adiponectin gene therapy of streptozotocin-induced diabetic mice using hydrodynamic injection. J. Gene Med., 2007, 9, 976.
45. Li, M.; Kim D.H.; Tsenovoy P.L.; Peterson S.J.; Rezzani R.; Rodella L.F.; Aronow W.S.; Ikehara S. and Abraham N.G. Treatment of obese diabetic mice with a heme oxygenase inducer reduces visceral and subcutaneous adiposity, increases adiponectin levels, and improves insulin sensitivity and glucose tolerance. Diabetes, 2008, 57, 1526.
46. Peterson, S.J.; Drummond G.; Hyun K.D.; Li M.; Kruger A.L.; Ikehara S. and Abraham N.G. L-4F treatment reduces adiposity, increases adiponectin levels and improves insulin sensitivity in obese mice. J. Lipid Res., 2008, 49, 1658.
47. Kim, D.H.; Burgess A.P.; Li M.; Tsenovoy P.L.; Addabbo F.; McClung J.A.; Puri N. and Abraham N.G. Heme oxygenasemediated increases in adiponectin decrease fat content and inflammatory cytokines, TNF and IL-6, in Zucker rats and reduce adipogenesis in human mesenchymal stem cells. J. Pharmacol. Exp. Ther., 2008, 325, 833.
48. Kushida, T.; Li Volti G.; Quan S.; Goodman A. and Abraham N.G. Role of human heme oxygenase-1 in attenuating TNF-alphamediated inflammation injury in endothelial cells. J. Cell Biochem., 2002, 87, 377.
49. Yamada, S.; Ito T.; Adachi J.; Ueno Y. and Shiomi M. Decreased arterial responses in WHHL rabbits, an animal model of spontaneous hypercholesterolemia and atherosclerosis. Exp. Anim., 2002, 51, 493.
50. Andreotti, F.; Porto I.; Crea F. and Maseri A. Inflammatory gene polymorphisms and ischaemic heart disease: review of population association studies. Heart, 2002, 87, 107.
51. Haeussler, U.; Riedel M. and Keller F. Free reactive oxygen species and nephrotoxicity of contrast agents. Kidney Blood Press Res., 2004, 27, 167.
52. Loomans, C.J.; de Koning E.J.; Staal F.J.; Rookmaaker M.B.; Verseyden C.; de Boer H.C.; Verhaar M.C.; Braam B.; Rabelink T.J. and van Zonneveld A.J. Endothelial progenitor cell dysfunction: a novel concept in the pathogenesis of vascular complications of type 1 diabetes. Diabetes, 2004, 53, 195.
53. Ouchi, N.; Shibata R. and Walsh K. Cardioprotection by adiponectin. Trends Cardiovasc. Med., 2006, 16, 141.
54. Fujio, Y.; Walsh K. Akt mediates cytoprotection of endothelial cells by vascular endothelial growth factor in an anchoragedependent manner. J. Biol. Chem., 1999, 274, 16349.
55. Brakenhielm, E.; Veitonmaki N.; Cao R.; Kihara S.; Matsuzawa Y.; Zhivotovsky B.; Funahashi T. and Cao Y. Adiponectin-induced antiangiogenesis and antitumor activity involve caspase-mediated endothelial cell apoptosis. Proc. Natl. Acad. Sci. USA, 2004, 101, 2476.
56. Secchiero, P.; Gonelli A.; Carnevale E.; Milani D.; Pandolfi A.; Zella D. and Zauli G. TRAIL promotes the survival and proliferation of primary human vascular endothelial cells by activating the Akt and ERK pathways. Circulation, 2003, 107, 2250.
57. Kumada, M.; Kihara S.; Ouchi N.; Kobayashi H.; Okamoto Y.; Ohashi K.; Maeda K.; Nagaretani H.; Kishida K.; Maeda N.; Nagasawa A.; Funahashi T. and Matsuzawa Y. Adiponectin specifically increased tissue inhibitor of metalloproteinase-1 through interleukin-10 expression in human macrophages. Circulation, 2004, 109, 2046.
58. Ouchi, N.; Kobayashi H.; Kihara S.; Kumada M.; Sato K.; Inoue T.; Funahashi T. and Walsh K. Adiponectin stimulates angiogenesis by promoting cross-talk between AMP-activated protein kinase and Akt signaling in endothelial cells. J. Biol. Chem., 2004, 279, 1304.
59. Ouchi, N.; Kihara S.; Arita Y.; Maeda K.; Kuriyama H.; Okamoto Y.; Hotta K.; Nishida M.; Takahashi M.; Nakamura T.; Yamashita S.; Funahashi T. and Matsuzawa Y. Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation, 1999, 100, 2473.
60. Pajvani, U.B.; Hawkins M.; Combs T.P.; Rajala M.W.; Doebber T.; Berger J.P.; Wagner J.A.; Wu M.; Knopps A.; Xiang A.H.; Utzschneider K.M.; Kahn S.E.; Olefsky J.M.; Buchanan T.A. and Scherer P.E. Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity. J. Biol. Chem., 2004, 279, 12152.
61. Schiekofer, S.; Galasso G.; Sato K.; Kraus B.J. and Walsh K. Impaired revascularization in a mouse model of type 2 diabetes is associated with dysregulation of a complex angiogenic-regulatory network. Arterioscler. Thromb. Vasc. Biol., 2005, 25, 1603.